Carbogen Inhalation Therapy for Epileptic Seizures: Mechanisms, Evidence, and Future Directions
Evidence supports carbogen's therapeutic promise and highlights the need for precise patient selection, controlled delivery, and comprehensive safety testing. Future research should develop biomarker-guided, closed-loop systems and test synergy with established ASMs to advance carbogen as a mechanism-based therapy within precision epilepsy care.
Authors
- Li Wang (ORCID: https://orcid.org/0000-0003-1427-3803)
- Qing Liu (ORCID: https://orcid.org/0000-0002-5774-7397)
- Y. Liu (ORCID: https://orcid.org/0009-0007-3730-9422)
- Meng Yang (ORCID: https://orcid.org/0000-0003-2290-1830)
- Wenwen Ding (ORCID: https://orcid.org/0009-0001-0935-0600)
- Fuqiang Xu (ORCID: https://orcid.org/0000-0002-4382-9797)
Institutions
- Chinese Academy of Sciences (CN)
- Center for Excellence in Brain Science and Intelligence Technology (CN)
- Jingchu University of Technology (CN)
- Wuhan National Laboratory for Optoelectronics (CN)
- Shenzhen Institutes of Advanced Technology (CN)
- University of Chinese Academy of Sciences (CN)
- Huazhong University of Science and Technology (CN)
- Air Force Medical University (CN)
Publication Details
- Journal
- CNS Neuroscience & Therapeutics
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/cns.70686
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00